Skip to main content
Assets
Johnson & Johnson logo
JNJ.NYSE
Johnson & Johnson
Health Care · Pharmaceuticals

Healthcare conglomerate specializing in pharmaceuticals, medical devices, and consumer health products with trusted global brands.

HQ: United StatesListed: United States

Profile & Fundamentals

Johnson & Johnson: Company identity, ownership, reported financial performance, balance sheets, and corporate actions.

Profile & Fundamentals

Johnson & Johnson Profile & Fundamentals

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables
Explore this pageJump to a Profile & Fundamentals section

Company and Market Context

Company Profile & Ownership

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ.NYSE

Company profile record

Johnson & Johnson

Common Stock · Health Care · Pharmaceuticals

Official website

Company

Company / asset
Johnson & Johnson
Security type
Common Stock
Sector
Health Care
Industry
Pharmaceuticals
HQ
🇺🇸 United States
Head office
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

Leadership & scale

Chief executive
Mr. Joaquin Duato
CEO year born
1963
Full-time employees
138.2K
Fiscal year end
December
IPO date
1944-09-24

Fundamentals snapshot

Updated 2026-09-09
Market Cap
USD 658.8B
P/E
31.3x
Revenue (Q2 26)
USD 25.3B
Profit (Q2 26)
USD 5.5B
Dividend Yield
1.4%
Revenue (FY 25)
USD 94.2B
Shares in public float
2.4B
Insider ownership
0.05%

Reporting & identifiers

Symbol
JNJ.NYSE
Listing
🇺🇸 United States | Dividend Tax: 30%
Ticker Currency
USD
Income Statement Currency
USD
Balance Sheet Currency
USD
Cash Flow Currency
USD
EPS Currency
USD
Contract Type
SPOT
ISIN
US4781601046
Asset ID
equity_c3269539-01b8-5845-8971-363e7e618c20

Ownership

Shares Outstanding

Shares OutstandingAnnual reported shares outstanding. Values in shares.2.37B2.47B2.58B2.68B2.78BJan 2017Apr 2019Jul 2021Oct 2023Jan 2026
  • Shares outstanding
Annual reported shares outstanding. Values in shares.

Top holders

  1. BlackRock Inc213,385,546 shares · 8.85% · Reported 2026-03-31
  2. Vanguard Capital Management, LLC156,605,370 shares · 6.50% · Reported 2026-03-31
  3. State Street Corp133,476,288 shares · 5.54% · Reported 2026-03-31
  4. Vanguard MStar Total Stk Mkt Idx Invest76,652,564 shares · 3.18% · Reported 2026-07-31
  5. Vanguard Portfolio Management, LLC63,514,436 shares · 2.64% · Reported 2026-03-31
  6. Vanguard 500 Index Investor63,192,258 shares · 2.62% · Reported 2026-07-31
  7. JPMorgan Chase & Co63,096,344 shares · 2.62% · Reported 2026-03-31
View more holders (8)
  1. Geode Capital Management, LLC59,164,862 shares · 2.46% · Reported 2026-03-31
  2. Morgan Stanley - Brokerage Accounts44,721,167 shares · 1.86% · Reported 2026-03-31
  3. iShares Core S&P 500 ETF32,055,505 shares · 1.33% · Reported 2026-08-31
  4. NORGES BANK31,825,084 shares · 1.32% · Reported 2026-06-30
  5. State Farm Mutual Automobile Ins Co31,590,952 shares · 1.31% · Reported 2026-06-30
  6. Fidelity 500 Index31,127,834 shares · 1.29% · Reported 2026-07-31
  7. State Street® SPDR® S&P 500® ETF29,507,724 shares · 1.22% · Reported 2026-08-31
  8. Northern Trust Corp29,319,669 shares · 1.22% · Reported 2026-03-31

Earnings, Profitability & Valuation

Earnings & Revenue

Revenue, Net Income, and Free Cash Flow

Revenue, Net Income, and Free Cash FlowAnnual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.-7.99B19.88B47.75B75.61B103.48BDec 2016Apr 2019Jul 2021Oct 2023Dec 2025
  • Revenue
  • Free cash flow
  • Net income
Annual reported financial results, converted using the statement's recorded USD conversion. Missing values are omitted. Values in USD.

Valuation

Historical P/E Ratio

Historical P/E RatioPublished valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.9.313.9218.5323.1527.77Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
  • Published P/E
Published valuation snapshots. Trailing four-quarter earnings where available; annual earnings otherwise. Non-positive earnings are omitted. Values in times earnings.

Profitability & Margins

Profitability Margins

Profitability MarginsAnnual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.-5.1615.4235.9956.5677.14Dec 2016Apr 2019Jul 2021Oct 2023Dec 2025
  • Gross margin
  • Operating margin
  • Net margin
  • Free cash flow margin
Annual gross, operating, net income and free cash flow divided by revenue for matching reporting dates. Values in percent.

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open the complete profile & fundamentals and available source data.